TraceBook: the Clinical Proof of Concept on the Intensive Care. (TraceBook)

January 31, 2019 updated by: Ashley De Bie, Catharina Ziekenhuis Eindhoven
The effectiveness of current checklists is hampered by lack of acceptance and compliance. Recently, a new type of checklist with dynamic properties has been created to provide more specific checklist items for each individual patient. The proof of concept of this dynamic clinical checklist (DCC; BJA 2017 (DOI: 10.1093/bja/aex129)) was tested in a simulation trial with improved outcomes and high acceptance scores. The purpose of this study is to investigate if the outcomes of this real-life clinical proof of concept study are similar with the outcomes of the simulation trial for the intensive care unit (ICU) ward.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Method A prospective single center (Catharina Hospital Eindhoven) controlled before-and-after study.

The before period will be used as control group in which ward rounds and nurse handovers will be observed by the investigators for two months. Then TraceBook will be introduced and clinicians, ICU doctors and nurses, will be able to use checklists of TraceBook for ward rounds, their shifts and handovers in which they will be observed for two months. The goal is at least 120 observations per period.

Endpoints The primary outcome is the percentage of items that were checked per ward rounds and nurse handovers during the before and the after implementation period. Secondary outcomes will be clinical outcomes of admitted patients, pharmacist specific outcomes, specific checkable item related outcomes, and user experience and acceptance scores.

Hypothesis TraceBook, with the use of digital dynamic checklists, improves compliance to care processes on the intensive care with a high user acceptance score.

Study Type

Interventional

Enrollment (Actual)

408

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Noord-Brabant
      • Eindhoven, Noord-Brabant, Netherlands, 5623 EJ
        • Catharina Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Physicians working on the ICU
  • All admitted patients on the ICU during the study periods.

Exclusion Criteria:

  • Physicians objecting participation in the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: "Before" control group
Control group with observation of current local standard of care with paper checklist available at the bedside during the ICU rounds of the ICU physicians (as usual)
Experimental: "After" Intervention group
An mini Ipad providing TraceBook' intelligent dynamic clinical checklists during the ICU rounds of the ICU physicians.
TraceBook offers the user intelligent dynamic clinical checklist that shows patient specific items to a specific user while being context aware.
Other Names:
  • Dynamic clinical checklist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Checked items
Time Frame: 24 hours (each day)
The percentage of daily checked checkable items overall and items requiring an intervention per patient.
24 hours (each day)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: 9 months
Intensive Care mortality
9 months
Mortality
Time Frame: 9 months
30 day mortality
9 months
Mortality
Time Frame: 9 months
90 day mortality
9 months
Length of stay
Time Frame: 9 months
Length of stay at the intensive care
9 months
Ventilator days
Time Frame: 9 months
Number of days with use of mechanical ventilator (per patient and overall per period)
9 months
Sedation days
Time Frame: 9 months
Number of patient days with a Richmond Agitation-Sedation Scale (score -5 till +4) between -5 and -1 as worse outcome.
9 months
Daily intensive care medication alerts
Time Frame: 4 months
Number of daily intensive care medication alerts for the pharmacist.
4 months
Pharmacists' interventions
Time Frame: 4 months
Types of pharmacists' interventions based on the daily intensive care medication alerts
4 months
Number of gastro-intestinal bleedings
Time Frame: 4 months
The number of patients during each period with hematemesis or melena, not being the reason of admission.
4 months
Ventilator and hospital associated pneumonia on the intensive care.
Time Frame: 4 months
The number of patients during each period with ventilator and hospital associated pneumonia, not being the reason of admission.
4 months
Central-venous-catheter-related bloodstream infections.
Time Frame: 4 months
The number of patients during each period with central-venous-catheter-related bloodstream infections, not being the reason of admission.
4 months
Incorrect prescribed anticoagulation or thrombosis prophylaxis.
Time Frame: 4 months
Number of patient days where anticoagulation or thrombosis prophylaxis is prescribed incorrect based on local protocol.
4 months
Incorrect prescribed proton pump inhibitors
Time Frame: 4 months
Number of patient days where proton pump inhibitors are prescribed incorrect based on local protocol.
4 months
Incorrect prescribed selective digestive decontamination
Time Frame: 4 months
Number of patient days where selective digestive decontamination is prescribed incorrect based on local protocol.
4 months
Spontaneous breathing trials
Time Frame: 4 months
Number of spontaneous breathing trials when required based on local protocol in weaning patients
4 months
Sedation wake up calls
Time Frame: 4 months
Number of sedation wake up calls when required based on local protocol
4 months
Intravenous sedatives use
Time Frame: 4 months
Number of patient days with the use of intravenous sedatives (eg Propofol, Midazolam)
4 months
Opiates use
Time Frame: 4 months
Number of patient days with the use of opiates overall and in patients with low Visual Analogue Scale scores (<4).
4 months
Antibiotics use
Time Frame: 4 months
Number of patient days with the use of antibiotics overall and when not required based on local protocol.
4 months
Complication registration
Time Frame: 4 months
Number of complications that were discussed within 24hrs and registered.
4 months
Energy deficit
Time Frame: 4 months
Number of patient days with energy deficit of >250.
4 months
Automatically checked items
Time Frame: 4 months
Number of items that where or could have been checked automatically during each period.
4 months
User experience outcomes
Time Frame: 6 months
Attrakdiff questionnaire after both periods Technology Acceptance Model 2 (TAM2) based questionnaire Semi-structured interview
6 months
Hedonic and pragmatic quality
Time Frame: 6 months
Attrakdiff questionnaire
6 months
User acceptance
Time Frame: 6 months
Technology Acceptance Model 2 (TAM2) based questionnaire after both periods to compare paper checklist and electronic health records with digital checklist and electronic health records.
6 months
User experience
Time Frame: 6 months
Semi-structured interview after the intervention period.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Erik Korsten, Prof MD, Catharina Ziekenhuis Eindhoven

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 2, 2018

Primary Completion (Anticipated)

February 12, 2019

Study Completion (Anticipated)

June 1, 2019

Study Registration Dates

First Submitted

June 29, 2018

First Submitted That Met QC Criteria

July 24, 2018

First Posted (Actual)

July 26, 2018

Study Record Updates

Last Update Posted (Actual)

February 4, 2019

Last Update Submitted That Met QC Criteria

January 31, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

IPD is available if researchers ask for it.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

3
Subscribe